Masthead Security Wireless Internet Cable Telephone email
ADVERTISEMENT
Today's Health Headlines
SEOUL (Reuters) - South Korea's tally of patients of Middle East Respiratory Syndrome (MERS) rose to seven on Thursday, with authorities saying one suspected victim skipped out of voluntary home quarantine to take a trip to China.

(Reuters) - New data to be released this weekend should help deepen the understanding of how broadly new drugs that unleash the body's immune system to fight cancer can be used.

NEW DELHI (Reuters) - A heat wave in India has killed at least 1,371 people this week as temperatures soar above 47 Celsius (116.6 Fahrenheit), and doctors' leave has been cancelled to help cope with the sick.

MEXICO CITY (Reuters) - Mexico is working hard to prevent outbreaks of a bird flu epidemic that has stricken the U.S. poultry and egg industry in recent months, a senior Mexican agriculture ministry official said on Wednesday.

WASHINGTON (Reuters) - U.S. health regulators approved new irritable bowel syndrome drugs from Actavis Plc and Valeant Pharmaceuticals International Inc on Wednesday, validating big investments both companies made to acquire the products.

NEW YORK (Reuters Health) - A 13-year tally of deaths and poisonings from ephedra show a spectacular decline after the U.S. Food and Drug Administration banned the sale of weight loss products containing the herb in 2004.

(Reuters Health) - Among African American adults with low education and income levels, the increase in risk of heart disease or stroke associated with living in poverty is largest for women and people under age 50, according to a large new study.

(Reuters Health) - Gruesome photographs on cigarette packages may deliver more effective anti-smoking messages than words, a new analysis finds.

SAN FRANCISCO (Reuters) - California scientists are testing whether the illegal psychoactive drug commonly known as Ecstasy could help alleviate anxiety for terminally ill patients, the trial's principal funder said on Tuesday.

(Reuters) - The Federal Bureau of Investigation is probing a surgical tool found to spread uterine cancer and what Johnson & Johnson knew about its risks before withdrawing its version of the device last year, the Wall Street Journal reported.

ADVERTISEMENT
Log Into Your sktc.net Account
MY ACCOUNT
MORE HEADLINES
thumbnail
ATLANTA (Reuters) - A plane carrying a second American aid ......
thumbnail
LONDON (Reuters) - Expectations are building for a new ......
BANGKOK (Reuters) - Authorities in Thailand are to inspect ......
NEW YORK (Reuters Health) - Under the Affordable Care Act, ......
Authorities have been monitoring anyone who came into ......
thumbnail
TOKYO (Reuters) - Japan's biggest drugmaker Takeda ......
thumbnail
FREETOWN/MONROVIA (Reuters) - Hundreds of troops deployed ......
NEW YORK (Reuters Health) - Hepatitis C may become a ......
thumbnail
WASHINGTON (Reuters) - International development banks on ......
NEW YORK (Reuters Health) - Physical therapy and steroid ......
ADVERTISEMENT
loading